Paid

First-line immunotherapy treatment can improve survival for subset of lung cancer patients

Findings from a phase III clinical trial for advanced lung cancer patients could help oncologists better predict which patients are likely to receive the most benefit from immunotherapy as a first-line treatment based on the unique molecular characteristics of their tumor, according to a new study reported by a global team led by David Carbone of Ohio State University Comprehensive Cancer–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
In Brief

Edith Mitchell receives 2017 ASTRO Honorary Membership

Edith Peterson Mitchell, researcher, medical oncologist, and retired brigadier general was chosen as the 2017 American Society for Radiation Oncology Honorary Member. Mtchell will receive the award on Sept. 26 at ASTRO's 59th Annual Meeting in San Diego. “Dr. Edith Mitchell has been a longtime proponent of combined modality treatment—using chemotherapy and radiation therapy together in order to provide cancer patients with the best possible outcomes,” says ASTRO chair David Beyer. “Our specialty is privileged to have a champion such as Dr. Mitchell, who is a widely respected clinician as well as decorated military veteran. Her service to both our country and our field is laudable.”